MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 17 06 2020
accepted: 18 11 2020
revised: 30 09 2020
pubmed: 6 1 2021
medline: 24 6 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

To assess the multiparametric MRI (mpMRI) appearances of normal peripheral zone (PZ) across age groups in a biopsy-naïve population, where prostate cancer (PCa) was subsequently excluded, and propose a scoring system for background PZ changes. This retrospective study included 175 consecutive biopsy-naïve patients (40-74 years) referred with a suspicion of PCa, but with subsequent negative investigations. Patients were grouped by age into categories ≤ 54, 55-59, 60-64, and ≥ 65 years. MpMRI sequences (T2-weighted imaging [T2WI], diffusion-weighted imaging [DWI]/apparent diffusion coefficient [ADC], and dynamic contrast-enhanced imaging [DCE]) were independently evaluated by two uro-radiologists on a proposed 4-point grading scale for background change on each sequence, wherein score 1 mirrored PIRADS-1 change and score 4 represented diffuse background change. Peripheral zone T2WI signal intensity and ADC values were also analyzed for trends relating to age. There was a negative correlation between age and assigned background PZ scores for each mpMRI sequence: T2WI: r = - 0.52, DWI: r = - 0.49, DCE: r = - 0.45, p < 0.001. Patients aged ≤ 54 years had mean scores of 3.0 (T2WI), 2.7 (DWI), and 3.1 (DCE), whilst patients ≥ 65 years had significantly lower mean scores of 1.7, 1.4, and 1.9, respectively. There was moderate inter-reader agreement for all scores (range κ = 0.43-0.58). Statistically significant positive correlations were found for age versus normalized T2WI signal intensity (r = 0.2, p = 0.009) and age versus ADC values (r = 0.33, p = 0.001). The normal PZ in younger patients (≤ 54 years) demonstrates significantly lower T2WI signal intensity, lower ADC values, and diffuse enhancement on DCE, which may hinder diagnostic interpretation in these patients. The proposed standardized PZ background scoring system may help convey the potential for diagnostic uncertainty to clinicians. • Significant, positive correlations were found between increasing age and higher normalized T2-weighted signal intensity and mean ADC values of the prostatic peripheral zone. • Younger men exhibit lower T2-weighted imaging signal intensity, lower ADC values, and diffuse enhancement on dynamic contrast-enhanced imaging, which may hinder MRI interpretation. • A scoring system is proposed which aims towards a standardized assessment of the normal background PZ. This may help convey the potential for diagnostic uncertainty to clinicians.

Identifiants

pubmed: 33398421
doi: 10.1007/s00330-020-07545-7
pii: 10.1007/s00330-020-07545-7
pmc: PMC8213603
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4908-4917

Références

Bray F, Ferlay J, Soerjomataram I (2018) Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 394–424. https://doi.org/10.3322/caac.21492
Stamey TA, Caldwell M, McNeal JE et al (2004) The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 172:1297–1301. https://doi.org/10.1097/01.ju.0000139993.51181.5d
doi: 10.1097/01.ju.0000139993.51181.5d pubmed: 15371827
US Preventive Services Task Force (2018) Final Recommendation Statement: Prostate Cancer: Screening. US Preventive Services Task Force, Rockville, MD, USA. Available via https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancerscreening1#table-of-contents . Accessed 17 Jun 2020
Fulgham PF, Rukstalis DB, Turkbey IB et al (2017) AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer. J Urol 198:832–838. https://doi.org/10.1016/j.juro.2017.04.101
doi: 10.1016/j.juro.2017.04.101 pubmed: 28483574 pmcid: 7905434
Mottet N, van den Bergh RCN, Briers E, et al (2020) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. https://doi.org/10.1016/j.eururo.2020.09.042
Xu Y, Wang Y, Zhou R et al (2016) The benign mimickers of prostatic acinar adenocarcinoma. Chin J Cancer Res 28:72–79. https://doi.org/10.3978/j.issn.1000-9604.2016.01.01
de Rooij M, Israël B, Tummers M et al (2020) ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training. Eur Radiol. https://doi.org/10.1007/s00330-020-06929-z
Rosenkrantz AB, Taneja SS (2013) Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 202:109–120. https://doi.org/10.2214/AJR.13.10699
doi: 10.2214/AJR.13.10699
Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757. https://doi.org/10.1007/s00330-011-2377-y
doi: 10.1007/s00330-011-2377-y pubmed: 22322308 pmcid: 3297750
Barrett T, Turkbey B, Choyke PL (2015) PI-RADS version 2: what you need to know. Clin Radiol 70:1165–1176. https://doi.org/10.1016/j.crad.2015.06.093
doi: 10.1016/j.crad.2015.06.093 pubmed: 26231470 pmcid: 6369533
Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 0232:1–12. https://doi.org/10.1016/j.eururo.2019.02.033
doi: 10.1016/j.eururo.2019.02.033
McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12:897–906. https://doi.org/10.1097/00000478-198812000-00001
doi: 10.1097/00000478-198812000-00001 pubmed: 3202246 pmcid: 3202246
Latifoltojar A, Dikaios N, Ridout A et al (2015) Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate. Prostate Cancer Prostatic Dis 18:343–351. https://doi.org/10.1038/pcan.2015.33
doi: 10.1038/pcan.2015.33 pubmed: 26195470 pmcid: 4763162
Lovegrove CE, Matanhelia M, Randeva J et al (2018) Prostate imaging features that indicate benign or malignant pathology on biopsy. Transl Androl Urol 7:420–435. https://doi.org/10.21037/tau.2018.07.06
doi: 10.21037/tau.2018.07.06
Barrett T, Rajesh A, Rosenkrantz AB et al (2019) PI-RADS version 2.1: one small step for prostate MRI. Clin Radiol 74:841–852. https://doi.org/10.1016/j.crad.2019.05.019
doi: 10.1016/j.crad.2019.05.019 pubmed: 31239107
Williams AM, Simon I, Landis PK et al (1999) Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl 20:474–480. https://doi.org/10.1002/j.1939-4640.1999.tb02545.x
doi: 10.1002/j.1939-4640.1999.tb02545.x pubmed: 10452590
Ren J, Liu H, Wang H et al (2015) MRI to predict prostate growth and development in children, adolescents and young adults. Eur Radiol 25:516–522. https://doi.org/10.1007/s00330-014-3372-x
doi: 10.1007/s00330-014-3372-x pubmed: 25097135
Allen KS, Kressel HY, Arger PH, Pollack HM (1989) Age-related changes of the prostate: evaluation by MR imaging. AJR Am J Roentgenol 152:77–81. https://doi.org/10.2214/ajr.152.1.77
doi: 10.2214/ajr.152.1.77 pubmed: 2783293
De Visschere PJL, Vral A, Perletti G et al (2017) Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate. Eur Radiol 27:2095–2109. https://doi.org/10.1007/s00330-016-4479-z
doi: 10.1007/s00330-016-4479-z pubmed: 27491874
Rao AA, Feneis J, Lalonde C, Ojeda-Fournier H (2016) A pictorial review of changes in the BI-RADS fifth edition. Radiographics 36:623–639. https://doi.org/10.1148/rg.2016150178
doi: 10.1148/rg.2016150178 pubmed: 27082663
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174. https://doi.org/10.2307/2529310
doi: 10.2307/2529310 pubmed: 843571 pmcid: 843571
Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Lawrence Erlbaum Associates Publishers, Hillsdale, New Jersey
Tamada T, Sone T, Toshimitsu S et al (2008) Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. J Magn Reson Imaging 27:552–556. https://doi.org/10.1002/jmri.21117
doi: 10.1002/jmri.21117 pubmed: 18219616
Shi C, Zhang D, Xiao Z et al (2017) Ultrahigh b-values MRI in normal human prostate: Initial research on reproducibility and age-related differences. J Magn Reson Imaging 46:801–812. https://doi.org/10.1002/jmri.25629
doi: 10.1002/jmri.25629 pubmed: 28267238
Zaichick V, Zaichick S (2014) Age-related histological and zinc content changes in adult nonhyperplastic prostate glands. Age (Dordr) 36:167–181. https://doi.org/10.1007/s11357-013-9561-8
doi: 10.1007/s11357-013-9561-8
Zhang J, Tian W-Z, Hu C-H et al (2015) Age-related changes of normal prostate: evaluation by MR diffusion tensor imaging. Int J Clin Exp Med 8:11220–11224
pubmed: 26379927 pmcid: 4565310
Matsugasumi T, Fujihara A, Ushijima S et al (2017) Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA. BJU Int 120:497–504. https://doi.org/10.1111/bju.13823
doi: 10.1111/bju.13823 pubmed: 28220583
Turkbey B, Huang R, Vourganti S et al (2012) Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int 110:1642–1647. https://doi.org/10.1111/j.1464-410X.2012.11469.x
doi: 10.1111/j.1464-410X.2012.11469.x pubmed: 22973825
Stabile A, Dell’Oglio P, Soligo M et al (2019) Assessing the clinical value of positive multiparametric magnetic resonance imaging in young men with a suspicion of prostate cancer. Eur Urol Oncol 1–7. https://doi.org/10.1016/j.euo.2019.05.006
Gielchinsky I, Scheltema MJ, Cusick T et al (2018) Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50. Res Rep Urol 10:145–150. https://doi.org/10.2147/RRU.S169017
doi: 10.2147/RRU.S169017 pubmed: 30324096 pmcid: 6174906
Caglic I, Kovac V, Barrett T (2019) Multiparametric MRI - local staging of prostate cancer and beyond. Radiol Oncol 53:159–170. https://doi.org/10.2478/raon-2019-0021
doi: 10.2478/raon-2019-0021 pubmed: 31103999 pmcid: 6572496
Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 69:16–40. https://doi.org/10.1016/j.eururo.2015.08.052
doi: 10.1016/j.eururo.2015.08.052 pubmed: 26427566 pmcid: 26427566
Caglic I, Povalej Brzan P, Warren AY et al (2019) Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extension. Eur Radiol 29:5488–5497. https://doi.org/10.1007/s00330-019-06070-6
doi: 10.1007/s00330-019-06070-6 pubmed: 30887192 pmcid: 6719333
Baco E, Rud E, Vlatkovic L et al (2015) Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer. J Urol 193:466–472. https://doi.org/10.1016/j.juro.2014.08.084
doi: 10.1016/j.juro.2014.08.084 pubmed: 25150643
Boccon-Gibod L, van der Kwast T, Montironi R et al (2004) Handling and pathology reporting of prostate biopsies. Eur Urol 46:177–181. https://doi.org/10.1016/j.eururo.2004.04.006
doi: 10.1016/j.eururo.2004.04.006 pubmed: 15245810
Schatteman PH, Hoekx L, Wyndaele JJ et al (2000) Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 37:404–412. https://doi.org/10.1159/000020161
doi: 10.1159/000020161 pubmed: 10765070
Adamczyk P, Wolski Z, Butkiewicz R et al (2013) Inflammatory changes in biopsy specimens from patients with suspected prostate cancer. Cent Eur J Urol 66:256–262. https://doi.org/10.5173/ceju.2013.03.art2
doi: 10.5173/ceju.2013.03.art2
Kim SH, Choi MS, Kim MJ et al (2017) Validation of Prostate Imaging Reporting and Data System version 2 using an MRI-ultrasound fusion biopsy in prostate cancer diagnosis. AJR Am J Roentgenol 209:800–805. https://doi.org/10.2214/AJR.16.17629
doi: 10.2214/AJR.16.17629 pubmed: 28705064

Auteurs

Vlad Bura (V)

Department of Radiology, County Clinical Emergency Hospital, Cluj-Napoca, Cluj, Romania.

Iztok Caglic (I)

Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Box 218, Hills Road, Cambridge, CB2 0QQ, UK.

Ziga Snoj (Z)

Radiology Institute, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Nikita Sushentsev (N)

Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Box 218, Hills Road, Cambridge, CB2 0QQ, UK.

Alexandra S Berghe (AS)

Department of Radiology, County Clinical Emergency Hospital, Cluj-Napoca, Cluj, Romania.
Department of Medical Informatics and Biostatistics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Andrew N Priest (AN)

Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Box 218, Hills Road, Cambridge, CB2 0QQ, UK.

Tristan Barrett (T)

Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Box 218, Hills Road, Cambridge, CB2 0QQ, UK. tristan.barrett@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH